[go: up one dir, main page]

AR003470A1 - Composicion para proporcionar tratamiento o atenuacion mejorados de sintomas de resfrio, alergia, sinusitis o gripe compuesta por un activoanalgesico y un agente antihistaminico de ester de pirrilidona o piperidina - Google Patents

Composicion para proporcionar tratamiento o atenuacion mejorados de sintomas de resfrio, alergia, sinusitis o gripe compuesta por un activoanalgesico y un agente antihistaminico de ester de pirrilidona o piperidina

Info

Publication number
AR003470A1
AR003470A1 ARP960103779A AR10377996A AR003470A1 AR 003470 A1 AR003470 A1 AR 003470A1 AR P960103779 A ARP960103779 A AR P960103779A AR 10377996 A AR10377996 A AR 10377996A AR 003470 A1 AR003470 A1 AR 003470A1
Authority
AR
Argentina
Prior art keywords
salts
pharmaceutically acceptable
compositions
sinusitis
allergy
Prior art date
Application number
ARP960103779A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR003470A1 publication Critical patent/AR003470A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Esta invención se refiere a composiciones y métodos para proporcionar tratamiento o atenuación mejorada de síntomas de resfríos, alergia, sinusitisy/o gripe, mediante la administración de una cantidad segura y eficaz de una composición que contiene un agente analgésico y agentes antihistamínicos deéter de pirrolidina y piperidina. Los activos farmacéuticos analgésicos útiles en las composiciones de esta invención incluyen aspirina y acetaminofeno asícomo drogas antiinflamatorias sin esteroides (NSAIDS) seleccionadas de las siguientes categorías: derivados de ácido propiónico; derivados de ácidoacético; derivados de ácido fenámico; derivados de ácido bifenilcarboxílico; y oxicamas. Ejemplos de activos farmacéuticos analgésicos útiles en estainvención incluyen, entre otros, acetaminofeno, ácido acetilsalicílico, ibuprofeno, fenbuprofeno, flurbiprofeno, indometacina, quetoprofeno, naproxeno,sus sales farmacéuticamente aceptables, sus enantiómeros y mezclas.Elacetaminofeno, ibuprofeno y naproxeno son especialmente preferidos para su usoen composiciones de esta invención. La expresión sales farmacéuticamente aceptables se refiere a sales preparadas a partir de bases no tóxicasfarmacéuticamente aceptables, incluyendo bases orgánicas e inorgánicas. Las sales derivadas de bases no orgánicas incluyen sales de sodio, potasio, litio,amonio, calcio, magnesio, ferrosa, de zinc, manganosa, de aluminio, férrica, mangánica, etc. Las sales derivadas de bases no tóxicas farmacéuticamenteaceptables incluyen sales de aminas primarias, secundarias, terciarias y cuaternarias, aminas sustituidas, incluyendo aminas sustituidas de origennatural,aminas cíclicas y resinas de cambio de ion básico,por ej. trietilamina, tripropilamina, 2-dimetilaminoetanol, 2-dietilaminoetanol, lisina, arginina,
ARP960103779A 1995-07-28 1996-07-26 Composicion para proporcionar tratamiento o atenuacion mejorados de sintomas de resfrio, alergia, sinusitis o gripe compuesta por un activoanalgesico y un agente antihistaminico de ester de pirrilidona o piperidina AR003470A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50877595A 1995-07-28 1995-07-28
US61152896A 1996-03-05 1996-03-05

Publications (1)

Publication Number Publication Date
AR003470A1 true AR003470A1 (es) 1998-08-05

Family

ID=27056302

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103779A AR003470A1 (es) 1995-07-28 1996-07-26 Composicion para proporcionar tratamiento o atenuacion mejorados de sintomas de resfrio, alergia, sinusitis o gripe compuesta por un activoanalgesico y un agente antihistaminico de ester de pirrilidona o piperidina

Country Status (8)

Country Link
EP (1) EP0841947A1 (es)
JP (1) JPH11510168A (es)
AR (1) AR003470A1 (es)
AU (1) AU6599196A (es)
CA (1) CA2227958A1 (es)
CO (1) CO4750820A1 (es)
PE (1) PE12098A1 (es)
WO (1) WO1997004808A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
US5770618A (en) * 1996-11-13 1998-06-23 Nastech Pharmaceutical Company, Inc. Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
BR9812660A (pt) * 1997-09-19 2000-08-22 Procter & Gamble Composições e métodos para tratar distúrbios respiratórios
US7014867B2 (en) 2001-06-28 2006-03-21 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
WO2003020258A1 (en) * 2001-09-04 2003-03-13 Boehringer Ingelheim International Gmbh Anti-influenza drugs
US7863287B2 (en) 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
RU2286770C2 (ru) * 2004-11-22 2006-11-10 Закрытое акционерное общество "Научно-производственное объединение "Антивирал" (ЗАО "НПО "Антивирал") Антигриппозное средство
JP5598108B2 (ja) * 2009-07-09 2014-10-01 ライオン株式会社 内服用固形組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222406A (ja) * 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
WO1992005783A1 (en) * 1990-09-28 1992-04-16 Merck & Co., Inc. Ibuprofen-antihistamine combinations
CA2122719A1 (en) * 1991-11-19 1993-05-27 Jack M. Gwaltney, Jr. Combined virustatic antimediator (covam) treatment of common colds
GB9222849D0 (en) * 1992-10-31 1992-12-16 Smithkline Beecham Plc Novel use of pharmaceutical compositions
BR9307697A (pt) * 1992-12-21 1999-05-25 Procter & Gamble Composições contendo cafeína e s(+)-ibuprofeno ou s(+)-flubiprofeno ou s(+)-quetoprofeno

Also Published As

Publication number Publication date
WO1997004808A1 (en) 1997-02-13
PE12098A1 (es) 1998-04-19
CO4750820A1 (es) 1999-03-31
CA2227958A1 (en) 1997-02-13
AU6599196A (en) 1997-02-26
JPH11510168A (ja) 1999-09-07
EP0841947A1 (en) 1998-05-20

Similar Documents

Publication Publication Date Title
AR003470A1 (es) Composicion para proporcionar tratamiento o atenuacion mejorados de sintomas de resfrio, alergia, sinusitis o gripe compuesta por un activoanalgesico y un agente antihistaminico de ester de pirrilidona o piperidina
JP5450910B1 (ja) ロキソプロフェンを含有する医薬組成物
BR9611015A (pt) Composto, composição farmacêutica e processo para o tratamento de uma doença inflamatória suscetìvel ao tratamento com um agente não-tóxico anti-inflamatório não-esteróide, sal farmaceuticamente aceitável, utilização de um composto
Ligumsky et al. Rectal Administration of Nonsteroidal Andinflammatory Drugs: Effect on Rat Gastric Ulcerogenicity and Prostaglandin E2 Synthesis
AR029819A1 (es) Parche con pantalla ultravioleta
WO1988008302A1 (en) Cough/cold mixtures comprising non-sedating antihistamine drugs
BR9803300A (pt) Formulação farmacêutica.
JP6144944B2 (ja) ロキソプロフェンを含有する医薬組成物
NO20001290L (no) Multiple-enhet sammensetninger av ikke-steroid anti- inflammatorisk medikament substans (NSAID) med modifisert frigjøring
BR9815549A (pt) Composição farmacêutica para administração em dose única diária para alteração de lipìdios num indivìduo sem causar hepatotoxicidade induzida por drogas, miopatia ou rabdomiólise, comprimido revestido e método para administração de dita composição
CO5280050A1 (es) Desnaturalizantes para las sales aminas simpaticomimeticas
CO6180502A2 (es) Comprimido masticable que contiene fenilefrina
UY24816A1 (es) Sulfonamidas agonistas de prostaglandinas para la prevención y restauración de la masa ósea
DE60318159D1 (de) Pharmazeutische Salze von Lokalanästhetischen zusammen mit antiinflammatorischen Verbindungen und Verfahren zur Herstellung der Salze
CA2519195A1 (en) Adhesive patch containing non-steroidal anti-inflammatory agent
CO5011084A1 (es) Composiciones y metodos para tratar trastornos respiratorios
AR014012A1 (es) Formula de liberacion prolongada
KR880010767A (ko) 비스테로이드성 소염제를 함유하는 약제학적 제제
NZ312997A (en) use of a non-steroidal anti-inflammatory agent for treating colonic adenomas
KR920002148A (ko) 비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
FR2385398A1 (fr) Compositions anti-inflammatoires contenant un compose du type phosphonate et un compose du type salicylate
RU2003115093A (ru) Болеутоляющие композиции, содержащие ненаркотический анальгетик и усилитель анальгезии
SE9401005L (sv) Farmaceutisk komposition med analgetisk aktivitet
GT199100052A (es) Composiciones farmaceuticas y metodos para aliviar sintomas gastrointestinales inducidos por drogas antiinflamatorias noesteroidales
NO972377D0 (no) Indolderivater og medisinsk anvendelse derav